ipamorelin e tesamorelin and Blend 8mg (6mg / 2mg) Tesamorelin + Ipamorelin | Synthesis

This educational protocol presents a once-daily subcutaneous approach using practical dilution for precise insulin-syringe measurements

GH IGF-1 downstream anabolic effects GH released by ipamorelin acts on hepatic GH receptors to induce IGF-1 production, which mediates most of the classically "anabolic" effects attributed to GH (protein synthesis, lipolysis, nitrogen retention, bone turnover)

Specifically, this diversity in mechanisms might alter both the amplitude and timing of GH output compared with either peptide alone, and combined experimentation might limit receptor-specific desensitization

How does the combined GH release compare to using each peptide alone

Yes, excessive dosing beyond 300 mcg of each peptide provides diminishing returns while increasing side effect risk and cost

Hybridization can be performed under conditions of various stringency